Monograph Details
|
|
Gastrointestinal Tract
> Hyperacidity, GERD, and ulcers
|
|
CARAFATE SUSPENSION |
| Manufacturer |
|
Axcan Pharma |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Cytoprotectant. |
| Generic Name |
|
Sucralfate 1g/10mL. |
| Also |
|
• CARAFATE
|
| Indications |
|
Active duodenal ulcer. Maintenance of healed duodenal ulcers (tabs only). |
| Children |
|
Not recommended. |
| Adults |
|
Active: 1g 4 times daily on an empty stomach for 4–8 weeks. Maintenance: 1g 2 times daily. |
| Precautions |
|
Chronic renal failure. Dialysis. Pregnancy (Cat.B). Nursing mothers. |
| Interactions |
|
Avoid antacids within 30 minutes of dosing. May reduce absorption of tetracyclines, phenytoin, cimetidine, digoxin, ciprofloxacin, norfloxacin, ketoconazole, ranitidine, theophylline; dose concomitant drugs 2 hrs after sucralfate. Additive aluminum load with aluminum-containing antacids. Monitor warfarin. |
| Adverse Reactions |
|
Constipation, GI disturbances. |
| How Supplied |
Tabs—100, 120, 500
Susp—14oz |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
